Miragen Therapeutics, Inc. Stock News

Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...

Signal Genetics, Inc. (MGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BOULDER, Colo., April 23, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, t

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ...

Miragen Therapeutics, Inc. (NASDAQ:MGEN) just released its annual report and things are looking bullish. Results...

BOULDER, Colo., March 11, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), today reported operating highlights and financial results for the quarter and full-year ended December 31, 201

NEW YORK, NY / ACCESSWIRE / March 11, 2020 / Miragen Therapeutics, Inc. (NASDAQ:MGEN) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 11, 2020

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and...

When Novartis signed on as a partner to Pliant Therapeutics last fall, it also agreed to eventually take an equity stake in the smaller biotech. The Swiss

ServiceSource (NASDAQ: SREV) Announces Four New Appointments to Board of Directors

BOULDER, Colo., Feb. 20, 2020 -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted.

Is (MGEN) Outperforming Other Medical Stocks This Year?

Salarius Pharmaceuticals (NASDAQ:SLRX) -53% after pricing equity offering.Resonant (NASDAQ:RESN) -31% after pricing equity offering.Myriad Genetics (NASDAQ:MYGN) -30% on Q2 earnings.Zogenix (NAS